BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31707511)

  • 1. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
    Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
    Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
    Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
    J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
    Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.
    Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP; Lee MM; Ambrosone CB; Kushi LH
    JAMA Oncol; 2017 Mar; 3(3):351-357. PubMed ID: 27832250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
    PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.
    Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC
    J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
    Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
    Bilinski K; Boyages J
    Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival.
    Thanasitthichai S; Prasitthipayong A; Boonmark K; Purisa W; Guayraksa K
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3101-3106. PubMed ID: 31653160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between alterations in the serum 25-hydroxyvitamin d status during follow-up and breast cancer patient prognosis.
    Lim ST; Jeon YW; Suh YJ
    Asian Pac J Cancer Prev; 2015; 16(6):2507-13. PubMed ID: 25824788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer.
    Webb PM; de Fazio A; Protani MM; Ibiebele TI; Nagle CM; Brand AH; Blomfield PI; Grant P; Perrin LC; Neale RE;
    Am J Clin Nutr; 2015 Jul; 102(1):109-14. PubMed ID: 25971716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer.
    Goodwin PJ; Ennis M; Pritchard KI; Koo J; Hood N
    J Clin Oncol; 2009 Aug; 27(23):3757-63. PubMed ID: 19451439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.
    Villaseñor A; Ballard-Barbash R; Ambs A; Bernstein L; Baumgartner K; Baumgartner R; Ulrich CM; Hollis BW; McTiernan A; Neuhouser ML
    Cancer Causes Control; 2013 Apr; 24(4):759-67. PubMed ID: 23361338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
    Hu K; Callen DF; Li J; Zheng H
    Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women.
    Palmer JR; Gerlovin H; Bethea TN; Bertrand KA; Holick MF; Ruiz-Narvaez EN; Wise LA; Haddad SA; Adams-Campbell LL; Kaufman HW; Rosenberg L; Cozier YC
    Breast Cancer Res; 2016 Aug; 18(1):86. PubMed ID: 27520657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of 25-hydroxyvitamin D level with survival outcomes in female breast cancer patients: A meta-analysis.
    Li C; Li H; Zhong H; Li X
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105947. PubMed ID: 34214604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Vitamin D and Risk of Breast Cancer within Five Years.
    O'Brien KM; Sandler DP; Taylor JA; Weinberg CR
    Environ Health Perspect; 2017 Jul; 125(7):077004. PubMed ID: 28728134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma.
    Loehrer E; Betensky RA; Giovannucci E; Su L; Shafer A; Hollis BW; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1379-1387. PubMed ID: 31186263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.